— Know what they know.
Not Investment Advice
Also trades as: 5CV.DE (XETRA) · $vol 1M · 5CV.F (FSX) · $vol 0M

CVAC NASDAQ

CureVac N.V.
1W: +7.4% 1M: -13.1% 3M: -16.3% 1Y: +42.6% 3Y: -28.1% 5Y: -95.5%
$4.66
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $1.0B mcap · 96M float · 1.22% daily turnover · Short 32% of daily vol

📊 Key Metrics

TTM
$511M
Revenue
+682.0% YoY
$194M
Net Income
+170.1% YoY
$196M
Free Cash Flow
+160.3% YoY
-77.8%
Gross Margin
-4959.5%
Op. Margin
-4783.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE40.2%
ROA31.1%
ROIC80.7%

Valuation

P/E4.4
P/B1.1
EV/EBITDA0.0

Leverage

Debt/Equity0.06
Current Ratio6.17
Interest Cov.547.9x

Quality Scores

Piotroski F8/9
Altman Z—
Beneish M-3.34

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms